Wide Ranks

BBLGW

BONE BIOLOGICS CORP C/WTS (TO P

27.80

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 11.22 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 2 M Total Cash Per Share 1.29 Total Debt
Total Debt To Equity Current Ratio 11.22 Book Value Per Share 5.44
All Measures
Message Board Id finmb_99330767 Return On Equity -1.19 City Burlington
Uuid 42b4cb99-4dca-3466-8e64-a3e9fa1107f6 Previous Close 26.00 First Trade Date Epoch Utc 1 B
Book Value 5.44 Beta 0.7360 Volume 578
Price To Book 5.11 Fifty Two Week Low 0.7000 Total Cash Per Share 1.29
Max Age 86400 Sand P52 Week Change 0.3133 Net Income To Common -5119297
Trailing Peg Ratio None Average Daily Volume10 Day 60 Average Volume10days 60
Total Cash 2 M Trailing PE 0.0000 Regular Market Previous Close 26.00
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 42.46
Open 27.80 Free Cashflow -4826930 State MA
Dividend Yield 0.00 % Return On Assets -0.5725 Time Zone Short Name EST
Trailing Eps -0.1440 Day Low 27.80 Address1 2 Burlington Woods Drive
Target High Price 0.0000 Price Hint 2 Website https://www.bonebiologics.com
52 Week Change 29.55 Average Volume 101 Recommendation Key none
Forward Eps 0.0000 Compensation As Of Epoch Date 1 B Quick Ratio 819.70 %
Is_sp_500 False Regular Market Day High 27.80 Profit Margins 0.00 %
Fifty Two Week High 70.44 Day High 27.80 Regular Market Open 27.80
Industry Key medical-devices Earnings Growth 0.00 % Revenue Growth 0.00 %
Operating Cashflow -6772514 Currency USD Time Zone Full Name America/New_York
Is_nasdaq_100 False Market Cap 0.0000 Zip 01803
Quote Type EQUITY Industry Medical Devices Long Name Bone Biologics Corporation
Regular Market Day Low 27.80 Current Price 27.80 Address2 Suite 100
Financial Currency USD Current Ratio 11.22 Industry Disp Medical Devices
Country United States Float Shares 1 M Two Hundred Day Average 39.06
Forward PE 0.0000 Regular Market Volume 578 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration.

It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.

The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications.

Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.